Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Go Back to All Clinical Trials

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Brief description of study

The purpose of this study is to determine if blood or stool can be used to detect colon cancers and advanced colon polyps as early, or earlier, than colonoscopy. The researchers plan to use these samples to learn about specific proteins biomarkers that may indicate the presence of colon polyps, colon cancer, or an increased risk of developing colon cancer. In order to learn more about preventing and detecting colon and rectal cancer, we are collecting samples from subjects with cancer, adenomas, and scheduled colonoscopies who may be at risk for polyps.

Clinical Study Identifier: s22-01229

ClinicalTrials.gov Identifier: NCT00843375

Principal Investigator: Aasma Shaukat.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies